A novel human IL2RB mutation results in T and NK cell-driven immune dysregulation

一种新型的人类IL2RB突变导致T细胞和NK细胞驱动的免疫失调

阅读:10
作者:Isabel Z Fernandez # ,Ryan M Baxter # ,Josselyn E Garcia-Perez ,Elena Vendrame ,Thanmayi Ranganath ,Daniel S Kong ,Karl Lundquist ,Tom Nguyen ,Sidney Ogolla ,Jennifer Black ,Csaba Galambos ,James C Gumbart ,Noor Dawany ,Judith R Kelsen ,Edwin F de Zoeten ,Ralph Quinones ,Hesham Eissa ,Michael R Verneris ,Kathleen E Sullivan ,Rosemary Rochford ,Catherine A Blish ,Ross M Kedl # ,Cullen M Dutmer # ,Elena W Y Hsieh #

Abstract

The pleiotropic actions of interleukin-2 (IL-2) are essential for regulation of immune responses and maintenance of immune tolerance. The IL-2 receptor (IL-2R) is composed of IL-2Rα, IL-2Rβ, and IL-2Rγ subunits, with defects in IL-2Rα and IL-2Rγ and their downstream signaling effectors resulting in known primary immunodeficiency disorders. Here, we report the first human defect in IL-2Rβ, occurring in two infant siblings with a homozygous IL2RB mutation in the WSXWS motif, manifesting as multisystem autoimmunity and susceptibility to CMV infection. The hypomorphic mutation results in diminished IL-2Rβ surface expression and dysregulated IL-2/15 signaling, with an anticipated reduction in regulatory T cells. However, in contrast to the IL-2Rβ-/- animal model, which lacks NK cells, these siblings demonstrate an expansion of NK cells, particularly the CD56bright subset, and a lack of terminally differentiated NK cells. Thus, the early-onset autoimmunity and immunodeficiency are linked to functional deficits arising from altered IL-2Rβ expression and signaling in T and NK cells.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。